新型冠状病毒肺炎与炎症性肠病实用最新进展：新型冠状病毒肺炎疾病风险及疫苗安全性与有效性
A Practical Update on COVID-19 and Inflammatory Bowel Disease: COVID-19 Disease Risk and Vaccine Safety and Efficacy.
作者信息
Schell Trevor L, Caldera Freddy
机构信息
Department of Internal Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
出版信息
Gastroenterol Hepatol (N Y). 2024 Feb;20(2):88-97.
Abstract
The COVID-19 pandemic introduced significant uncertainty regarding the care of patients with inflammatory bowel disease (IBD). Substantial research efforts have made progress in answering many of the questions that arose, but the constantly shifting paradigm of COVID-19-related research and recommendations has made it challenging for IBD clinicians to remain up-to-date. The goal of this article is to provide a concise and practical summary of the literature evaluating COVID-19 disease risk in addition to COVID-19 vaccine safety, immunogenicity, real-world effectiveness, and uptake among patients with IBD.
摘要
新冠疫情给炎症性肠病（IBD）患者的护理带来了极大的不确定性。大量研究工作在解答由此产生的许多问题方面取得了进展，但与新冠相关的研究和建议模式不断变化，使得IBD临床医生难以跟上最新进展。本文的目的是对评估新冠疾病风险以及新冠疫苗安全性、免疫原性、实际效果和IBD患者接种情况的文献进行简明实用的总结。
相似文献
1
A Practical Update on COVID-19 and Inflammatory Bowel Disease: COVID-19 Disease Risk and Vaccine Safety and Efficacy.
Gastroenterol Hepatol (N Y). 2024 Feb;20(2):88-97.
2
Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination.
Inflamm Bowel Dis. 2023 Aug 1;29(8):1202-1209. doi: 10.1093/ibd/izac193.
3
Humoral Immunogenicity of mRNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease and Healthy Controls.
Am J Gastroenterol. 2022 Jan 1;117(1):176-179. doi: 10.14309/ajg.0000000000001570.
4
Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines.
Gastroenterology. 2021 Aug;161(2):681-700. doi: 10.1053/j.gastro.2021.04.034.
5
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study.
Dig Liver Dis. 2023 Feb;55(2):154-159. doi: 10.1016/j.dld.2022.08.027. Epub 2022 Aug 29.
6
Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines.
Gastroenterology. 2021 Aug;161(2):669-680.e0. doi: 10.1053/j.gastro.2020.12.079. Epub 2021 Feb 19.
7
Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID.
Inflamm Bowel Dis. 2022 Oct 3;28(10):1497-1505. doi: 10.1093/ibd/izab302.
8
Misconceptions Drive COVID-19 Vaccine Hesistancy in Individuals with Inflammatory Bowel Disease.
Can J Gastroenterol Hepatol. 2022 Sep 10;2022:4527844. doi: 10.1155/2022/4527844. eCollection 2022.
9
[Inflammatory bowel disease during the COVID-19 pandemic: manifestations and management].
Z Gastroenterol. 2022 Dec;60(12):1795-1801. doi: 10.1055/a-1744-6697. Epub 2022 Feb 11.
10
Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic.
Gut. 2022 Jul;71(7):1426-1439. doi: 10.1136/gutjnl-2021-326784. Epub 2022 Apr 27.
引用本文的文献
1
SARS-CoV-2 Variant-Specific Antibodies in Vaccinated Inflammatory Bowel Disease Patients.
Vaccines (Basel). 2025 May 30;13(6):595. doi: 10.3390/vaccines13060595.
2
Impact of COVID-19 on Pediatric Inflammatory Bowel Diseases-From Expectations to Reality.
J Pers Med. 2024 Apr 9;14(4):399. doi: 10.3390/jpm14040399.
本文引用的文献
1
Additional COVID-19 Booster Doses Increase Anti-spike Serum Antibody Concentrations Among Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Oct 3;29(10):e38-e39. doi: 10.1093/ibd/izad068.
2
Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments.
Gut. 2024 Mar 7;73(4):712-714. doi: 10.1136/gutjnl-2022-329136.
3
Persistence of Antibodies Six Months after Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Oct 3;29(10):1662-1666. doi: 10.1093/ibd/izad019.
4
Risks of Development of COVID-19 Among Patients With Inflammatory Bowel Disease: A Comparative Assessment of Risk Factors for Incident Infection.
Crohns Colitis 360. 2022 Mar 29;4(2):otac011. doi: 10.1093/crocol/otac011. eCollection 2022 Apr.
5
COVID-19 Vaccine Effectiveness Against the Omicron Variant in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease.
Am J Gastroenterol. 2023 Apr 1;118(4):664-673. doi: 10.14309/ajg.0000000000002071. Epub 2022 Nov 26.
6
Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey.
J Gastroenterol. 2023 Mar;58(3):205-216. doi: 10.1007/s00535-022-01949-6. Epub 2023 Jan 6.
7
Effect of 2 vs 3 Doses of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease: A Population-based Propensity Matched Analysis.
Inflamm Bowel Dis. 2023 Oct 3;29(10):1563-1571. doi: 10.1093/ibd/izac252.
8
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Lancet Gastroenterol Hepatol. 2023 Feb;8(2):145-156. doi: 10.1016/S2468-1253(22)00389-2. Epub 2022 Dec 5.
9
Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2.
Aliment Pharmacol Ther. 2023 Jan;57(1):103-116. doi: 10.1111/apt.17264. Epub 2022 Oct 28.
10
Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease.
Lancet Gastroenterol Hepatol. 2022 Dec;7(12):1077-1079. doi: 10.1016/S2468-1253(22)00340-5. Epub 2022 Oct 26.
Zotero 插件